The Middle EAST Paroxysmal Nocturnal Hemoglobinuria Market was valued at USD 0.45 billion in 2024 and is projected to reach USD 1.20 billion by 2034, registering a CAGR of 10.0%. This growth trajectory is driven by a combination of increasing awareness of the disease, advancements in treatment options, and a rise in healthcare expenditure across the region. The demand for effective therapies is...